A recent study unveils a novel approach to combat acute myeloid #leukemia by targeting a specific cellular process called ferritinophagy. ow.ly/c8bu50TgTL1 #AML

The #FDA approved dostarlimab-gxly with carboplatin and paclitaxel, followed by single-agent dostarlimab-gxly, for adult patients with primary advanced or recurrent #EndometrialCancer. ow.ly/VQiR50TgVnG

Gretel Terrero, MD, Assistant Professor of Clinical Medicine in the Division of Medical Oncology, has been named a K12 2024 Faculty Scholar at Sylvester Comprehensive Cancer Center. ow.ly/foyf50ThqYf

The core arguments for universal germline genetic testing for #GIcancers are false, according to a presentation at the 2024 Great Debates & Updates in Gastrointestinal Malignancies meeting in New York. Keep reading: ow.ly/O2sp50ThsrK

Findings from an international, randomized, multicenter study suggest that targeted physical training can improve metastatic #breastcancer patients' quality of life. Keep reading: ow.ly/F3sJ50Tht6Z #CancerResearch

New findings from a multicenter, non-randomized clinical basket trial advocate for a broader and more inclusive design when establishing novel trials. Read the study here: ow.ly/oTea50ThtFw #CancerResearch

The phrase "losing the battle to cancer" can have a negative impact on patients. Instead, clinicians should inspire hope and prevent patients from perceiving dying as losing their battle, says Wendy S. Harpham, MD, FACP. ow.ly/SpTm50ThuMy Wendy S. Harpham

The #FDA approved daratumumab and hyaluronidase-fihj in combination with bortezomib, lenalidomide, and dexamethasone in patients with newly diagnosed #MultipleMyeloma. ow.ly/ZFMJ50TgVqy

In the first episode of HRD Testing in Advanced Ovarian Cancer, a 3-part podcast series sponsored by AstraZeneca, Dr Kathleen Moore discusses #HRD testing in #ovariancancer and its clinical significance in aiding precision medicine approaches. To listen: focusononcology.com/ovarian-cancer…

Newly published data revealed that #CancerSurvivors who identify as LGBTQ+ experience more chronic health conditions, disabilities, and other physical and cognitive limitations than non-LGBTQ+ cancer survivors. ow.ly/IKJF50ThtPb

Robert C. Gallo, MD, has joined Tampa General Hospital as Founder and Director of the Microbial Oncology Program at the TGH Cancer Institute and Senior Scientific Advisor to the Executive Director of the TGH Cancer Institute. ow.ly/haeY50TjcUy

“Our study adds to the body of evidence showing that bilateral #mastectomy in #breastcancer patients significantly reduces the risk of contralateral cancer, but does not improve survival,” said Vasily Giannakeas, PhD, MPH. Read the study: ow.ly/tKqr50Tjhtr

Oncology Times interviewed Katherine Reeder-Hayes, MD, at UNC School of Medicine, on the racial gap in survival after a breast cancer diagnosis. Read the interview here: ow.ly/iZyk50TjfI6 #BreastCancer

The #FDA granted accelerated approval to afamitresgene autoleucel for adults with unresectable or metastatic #SynovialSarcoma. ow.ly/KoOR50TgVuH

A new study found there was a relatively low risk of secondary #bloodcancers in the 3 years following CAR T-cell therapy. Read more: ow.ly/aZjk50TkEUV

Patients with rare cancers are significantly more likely to develop anxiety and depression, and they have higher incidence rates of suicide and post-traumatic stress disorder, according to a new study. Read more here: ow.ly/bNZR50TkEXp

Timothy Donahue, MD, Zev Wainberg, MD, and Caius Radu, MD, at UCLA, lead a team who received a National Cancer Institute grant to improve treatments and outcomes for people diagnosed with pancreatic cancer. ow.ly/Lf0q50ThrTF

Did you know Oncology Times has Online Only content? Published as a supplement to our print issues, Online Only covers new #research and #oncology news. Visit the site today: journals.lww.com/oncology-times…

In a new study, Johns Hopkins University researchers used machine learning and cell-free DNA fragmentation profiles to create a liquid biopsy for the #earlydetection of #lungcancer, promising to significantly increase annual screenings rates. ow.ly/4xAg50TlsQj

The American Society for Radiation Oncology (ASTRO) has voted Neha Vapiwala, MD, FACR, FASTRO, FASCO, to be President-Elect. ow.ly/noJu50TlskC ASTRO